| Product Code: ETC8896491 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Portugal continues to rely on key exporters such as Netherlands, Spain, USA, Sweden, and UK for therapeutic vaccines, with significant market concentration observed in 2024. The high Herfindahl-Hirschman Index (HHI) indicates a market dominated by a few major players. Despite a remarkable compound annual growth rate (CAGR) of 56.26% from 2020 to 2024, a slight decline in growth rate in 2024 suggests potential market stabilization. Monitoring these trends can provide valuable insights for stakeholders in the therapeutic vaccines import market in Portugal.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Therapeutic Vaccines Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Portugal Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Portugal Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Portugal Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Portugal Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Portugal Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Portugal |
4.2.2 Growing awareness about preventive healthcare measures |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine approval |
4.3.2 High costs associated with research and development of therapeutic vaccines |
5 Portugal Therapeutic Vaccines Market Trends |
6 Portugal Therapeutic Vaccines Market, By Types |
6.1 Portugal Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Portugal Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F |
6.1.4 Portugal Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F |
6.1.5 Portugal Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F |
6.2 Portugal Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Portugal Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F |
6.2.3 Portugal Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.2.4 Portugal Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F |
6.2.5 Portugal Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F |
6.2.6 Portugal Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Portugal Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Portugal Therapeutic Vaccines Market Export to Major Countries |
7.2 Portugal Therapeutic Vaccines Market Imports from Major Countries |
8 Portugal Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of individuals vaccinated with therapeutic vaccines |
8.2 Percentage of healthcare professionals recommending therapeutic vaccines |
8.3 Funding allocation towards research and development of therapeutic vaccines |
9 Portugal Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Portugal Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Portugal Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Portugal Therapeutic Vaccines Market - Competitive Landscape |
10.1 Portugal Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Portugal Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here